These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 10700602

  • 21. A comparison of sibutramine and dexfenfluramine in the treatment of obesity.
    Hanotin C, Thomas F, Jones SP, Leutenegger E, Drouin P.
    Obes Res; 1998 Jul; 6(4):285-91. PubMed ID: 9688105
    [Abstract] [Full Text] [Related]

  • 22. Increased release of serotonin from rat ileum due to dexfenfluramine.
    Rezaie-Majd S, Murar J, Nelson DP, Kelly RF, Hong Z, Lang IM, Varghese A, Weir EK.
    Am J Physiol Regul Integr Comp Physiol; 2004 Nov; 287(5):R1209-13. PubMed ID: 15242826
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine.
    Shankaran M, Yamamoto BK, Gudelsky GA.
    Eur J Pharmacol; 1999 Dec 03; 385(2-3):103-10. PubMed ID: 10607865
    [Abstract] [Full Text] [Related]

  • 25. Correlation between 5-HT content and uptake site density following (S)-MDMA and dexfenfluramine-induced depletion, and with neuroprotection by the glycine site-specific NMDA antagonist ACEA 1021.
    Russell BR, Laverty R.
    Ann N Y Acad Sci; 2000 Sep 03; 914():208-14. PubMed ID: 11085322
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain.
    Caccia S, Anelli M, Codegoni AM, Fracasso C, Garattini S.
    Br J Pharmacol; 1993 Sep 03; 110(1):355-9. PubMed ID: 7693282
    [Abstract] [Full Text] [Related]

  • 29. MDMA induced dopamine release in vivo: role of endogenous serotonin.
    Koch S, Galloway MP.
    J Neural Transm (Vienna); 1997 Sep 03; 104(2-3):135-46. PubMed ID: 9203077
    [Abstract] [Full Text] [Related]

  • 30. The potentiating effect of sertraline and fluoxetine on amphetamine-induced locomotor activity is not mediated by serotonin.
    Sills TL, Greenshaw AJ, Baker GB, Fletcher PJ.
    Psychopharmacology (Berl); 1999 Apr 03; 143(4):426-32. PubMed ID: 10367561
    [Abstract] [Full Text] [Related]

  • 31. Effects of standardized extracts of St. John's wort on the single-unit activity of serotonergic dorsal Raphe neurons in awake cats: comparisons with fluoxetine and sertraline.
    Fornal CA, Metzler CW, Mirescu C, Stein SK, Jacobs BL.
    Neuropsychopharmacology; 2001 Dec 03; 25(6):858-70. PubMed ID: 11750179
    [Abstract] [Full Text] [Related]

  • 32. 3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion.
    Orio L, O'Shea E, Sanchez V, Pradillo JM, Escobedo I, Camarero J, Moro MA, Green AR, Colado MI.
    J Neurochem; 2004 Jun 03; 89(6):1445-53. PubMed ID: 15189347
    [Abstract] [Full Text] [Related]

  • 33. No compelling evidence that sibutramine prolongs life in rodents despite providing a dose-dependent reduction in body weight.
    Smith DL, Robertson HT, Desmond RA, Nagy TR, Allison DB.
    Int J Obes (Lond); 2011 May 03; 35(5):652-7. PubMed ID: 21079617
    [Abstract] [Full Text] [Related]

  • 34. Cross tolerance between anorectic action and induction of Fos-ir with dexfenfluramine and 5HT1B/2C agonists in rats.
    Rowland NE, Robertson K, Lo J, Rema E.
    Psychopharmacology (Berl); 2001 Jun 03; 156(1):108-14. PubMed ID: 11465628
    [Abstract] [Full Text] [Related]

  • 35. Effects of 5-HT1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex.
    Dawson LA, Nguyen HQ.
    Eur J Pharmacol; 1998 Mar 12; 345(1):41-6. PubMed ID: 9593592
    [Abstract] [Full Text] [Related]

  • 36. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S, Sheth CS, Ombach HJ, Olson PR, Bogdanova OV, Petersen M, Renshaw CE, Sung YH, D'Anci KE, Renshaw PF.
    Pharmacol Biochem Behav; 2018 Jul 12; 170():25-35. PubMed ID: 29738811
    [Abstract] [Full Text] [Related]

  • 37. Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter (SERT).
    Kramer HK, Poblete JC, Azmitia EC.
    Neuropsychopharmacology; 1998 Oct 12; 19(4):265-77. PubMed ID: 9718590
    [Abstract] [Full Text] [Related]

  • 38. Dexfenfluramine. An updated review of its therapeutic use in the management of obesity.
    Davis R, Faulds D.
    Drugs; 1996 Nov 12; 52(5):696-724. PubMed ID: 9118819
    [Abstract] [Full Text] [Related]

  • 39. Effects of sibutramine on the appetitive and consummatory aspects of feeding in non-human primates.
    Foltin RW.
    Physiol Behav; 2006 Feb 28; 87(2):280-6. PubMed ID: 16352322
    [Abstract] [Full Text] [Related]

  • 40. Serotonergic and noradrenergic pathways are required for the anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in rats.
    Furmaga H, Shah A, Frazer A.
    Biol Psychiatry; 2011 Nov 15; 70(10):937-45. PubMed ID: 21907323
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.